{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:19Z","timestamp":1790673199671,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["MLN-4760"],"award-info":[{"award-number":["MLN-4760"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-113905"],"award-info":[{"award-number":["HL-113905"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005384","name":"American Physiological Society","doi-asserted-by":"publisher","award":["NIHHL-113905"],"award-info":[{"award-number":["NIHHL-113905"]}],"id":[{"id":"10.13039\/100005384","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.peptides.2020.170477","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:05:53Z","timestamp":1609585553000},"page":"170477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity"],"prefix":"10.1016","volume":"137","author":[{"given":"Yasmin","family":"Polak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-2136","authenticated-orcid":false,"given":"Robert C.","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"issue":"43","key":"10.1016\/j.peptides.2020.170477_bib0010","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J.Biol.Chem."},{"issue":"14","key":"10.1016\/j.peptides.2020.170477_bib0015","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0020","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.peptides.2020.170477_bib0025","article-title":"Trends in angiotensin receptor blocker use among those at risk for COVID-19 morbidity and mortality in the United States","author":"Perez","year":"2020","journal-title":"medRxiv"},{"issue":"5","key":"10.1016\/j.peptides.2020.170477_bib0030","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.peptides.2020.170477_bib0035","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.peptides.2020.170477_bib0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/CIRCRESAHA.109.208645","article-title":"Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension","volume":"106","author":"Feng","year":"2010","journal-title":"Circ.Res."},{"issue":"4","key":"10.1016\/j.peptides.2020.170477_bib0045","doi-asserted-by":"crossref","first-page":"e87845","DOI":"10.1371\/journal.pone.0087845","article-title":"New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure","volume":"9","author":"Uri","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.peptides.2020.170477_bib0050","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"14","key":"10.1016\/j.peptides.2020.170477_bib0055","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","article-title":"Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis","volume":"272","author":"Guy","year":"2005","journal-title":"FEBS J."},{"issue":"17","key":"10.1016\/j.peptides.2020.170477_bib0060","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.peptides.2020.170477_bib0065","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence","volume":"42","author":"Guy","year":"2003","journal-title":"Biochemistry"},{"issue":"Supp.1","key":"10.1016\/j.peptides.2020.170477_bib0070","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.RES.36.6.38","article-title":"Angiotensin III: (des-aspartic acid1)-angiotensin II Evidence and speculation for its role as an important agonist in the renin-angiotensin system","volume":"36 and 37","author":"Goodfriend","year":"1975","journal-title":"Circ.Res."},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0075","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0167-0115(92)90527-2","article-title":"Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor","volume":"40","author":"Swanson","year":"1992","journal-title":"Regul. Pept."},{"issue":"40","key":"10.1016\/j.peptides.2020.170477_bib0080","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J. Am. Chem. Soc."},{"issue":"6965","key":"10.1016\/j.peptides.2020.170477_bib0085","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2020.170477_bib0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2020.170477_bib0095","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.peptides.2020.170477_bib0100","doi-asserted-by":"crossref","first-page":"taaa027","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","volume":"27","author":"Diaz","year":"2020","journal-title":"J. Travel Med."},{"key":"10.1016\/j.peptides.2020.170477_bib0105","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.peptides.2020.170477_bib0110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ddr.21672","article-title":"Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections","volume":"81","author":"Speth","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.peptides.2020.170477_bib0115","doi-asserted-by":"crossref","first-page":"taaa045","DOI":"10.1093\/jtm\/taaa045","article-title":"Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic","volume":"27","author":"Speth","year":"2020","journal-title":"J. Travel Med."},{"key":"10.1016\/j.peptides.2020.170477_bib0120","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013Angiotensin\u2013Aldosterone system inhibitors in patients with Covid-19","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.peptides.2020.170477_bib0125","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. physiol. Heart circulatory physiol."},{"key":"10.1016\/j.peptides.2020.170477_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104832","article-title":"Angiotensin receptor blockers and COVID-19","volume":"156","author":"Saavedra","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"23","key":"10.1016\/j.peptides.2020.170477_bib0135","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.1111\/j.1742-4658.2008.06733.x","article-title":"Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis","volume":"275","author":"Rushworth","year":"2008","journal-title":"FEBS J."},{"issue":"Pt 1","key":"10.1016\/j.peptides.2020.170477_bib0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"issue":"17","key":"10.1016\/j.peptides.2020.170477_bib0145","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J.Biol.Chem."},{"issue":"4","key":"10.1016\/j.peptides.2020.170477_bib0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Can. J. Physiol Pharmacol."},{"issue":"S1","key":"10.1016\/j.peptides.2020.170477_bib0155","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.28.1_supplement.1067.4","article-title":"Concentration-dependent effects of zinc on angiotensin-converting enzyme-2 activity","volume":"28","author":"Speth","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2020.170477_bib0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2010146117","article-title":"Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates","author":"Damas","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1021\/bi00270a015","article-title":"Substrate specificity and kinetic characteristics of angiotensin converting enzyme","volume":"22","author":"B\u00fcnning","year":"1983","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0170","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1038\/s41598-017-06135-w","article-title":"Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family","volume":"7","author":"Raulinaitis","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0175","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0014-5793(96)01412-3","article-title":"Inhibition of carboxypeptidase A by excess zinc: analysis of the structural determinants by X-ray crystallography","volume":"400","author":"Gomez-Ortiz","year":"1997","journal-title":"FEBS Lett."},{"issue":"10","key":"10.1016\/j.peptides.2020.170477_bib0180","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/pro.5560041001","article-title":"Structural analysis of zinc substitutions in the active site of thermolysin","volume":"4","author":"Holland","year":"1995","journal-title":"Protein Sci."},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0185","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0021-9258(18)94228-6","article-title":"Mechanism of inhibition of human neutrophil collagenase by Gold(I) chrysotherapeutic compounds. Interaction at a heavy metal binding site","volume":"264","author":"Mallya","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.peptides.2020.170477_bib0190","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00204-011-0775-1","article-title":"Zinc and human health: an update","volume":"86","author":"Chasapis","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0002-8223(01)00078-5","article-title":"Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc","volume":"101","author":"Trumbo","year":"2001","journal-title":"J. Am. Diet. Assoc."},{"issue":"6","key":"10.1016\/j.peptides.2020.170477_bib0200","doi-asserted-by":"crossref","first-page":"e004647","DOI":"10.1136\/bmjopen-2013-004647","article-title":"Preventive zinc supplementation for children, and the effect of additional iron: a systematic review and meta-analysis","volume":"4","author":"Mayo-Wilson","year":"2014","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.peptides.2020.170477_bib0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/ajcn\/51.2.225","article-title":"Zinc toxicity","volume":"51","author":"Fosmire","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0210","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010038","article-title":"Prospective study of dietary zinc intake and risk of cardiovascular disease in women","volume":"10","author":"Milton","year":"2018","journal-title":"Nutrients"},{"issue":"5961","key":"10.1016\/j.peptides.2020.170477_bib0215","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/308734a0","article-title":"Release of endogenous Zn2+ from brain tissue during activity","volume":"308","author":"Assaf","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2020.170477_bib0220","doi-asserted-by":"crossref","DOI":"10.3949\/ccjm.87a.ccc046","article-title":"What is the role of supplementation with ascorbic acid, zinc, vitamin D, or N-acetylcysteine for prevention or treatment of COVID-19?","author":"Bauer","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.peptides.2020.170477_bib0225","first-page":"1","article-title":"Can Zn Be a critical element in COVID-19 treatment?","author":"Rahman","year":"2020","journal-title":"Biol. Trace Elem. Res."},{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/qjmed\/hcg004","article-title":"Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults","volume":"96","author":"Mossad","year":"2003","journal-title":"Qjm"},{"issue":"3","key":"10.1016\/j.peptides.2020.170477_bib0235","doi-asserted-by":"crossref","first-page":"e33211","DOI":"10.1371\/journal.pone.0033211","article-title":"Angiotensin II requires zinc and downregulation of the zinc transporters ZnT3 and ZnT10 to induce senescence of vascular smooth muscle cells","volume":"7","author":"Patrushev","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2020.170477_bib0240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1756-6606-6-50","article-title":"Angiotensin II potentiates zinc-induced cortical neuronal death by acting on angiotensin II type 2 receptor","volume":"6","author":"Park","year":"2013","journal-title":"Mol. Brain"},{"issue":"4","key":"10.1016\/j.peptides.2020.170477_bib0245","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/pr.118.017129","article-title":"Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure","volume":"71","author":"Arendse","year":"2019","journal-title":"Pharmacol. Rev."},{"issue":"17","key":"10.1016\/j.peptides.2020.170477_bib0250","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J.Biol.Chem."},{"issue":"40","key":"10.1016\/j.peptides.2020.170477_bib0255","doi-asserted-by":"crossref","first-page":"11852","DOI":"10.1021\/ja0277226","article-title":"Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors","volume":"124","author":"Dales","year":"2002","journal-title":"J Am. Chem. Soc."},{"key":"10.1016\/j.peptides.2020.170477_bib0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence","volume":"108","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.peptides.2020.170477_bib0265","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","volume":"81","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"1","key":"10.1016\/j.peptides.2020.170477_bib0270","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.109.161711","article-title":"The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor\/c-Met inhibitor","volume":"333","author":"Yamamoto","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120302266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978120302266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:39:29Z","timestamp":1777527569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978120302266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":54,"alternative-id":["S0196978120302266"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170477","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2020.170477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170477"}}